PBOV1 and glioma: Here we found that tumor samples from patients with proneural glioma who survived for more than 209 weeks showed significantly higher PBOV1 expression levels when compared to patients that survived 52–209 weeks (Figure 4C, one-tailed T-test p = 0.04).